Page last updated: 2024-08-26

fulvestrant and Experimental Mammary Neoplasms

fulvestrant has been researched along with Experimental Mammary Neoplasms in 29 studies

Research

Studies (29)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (31.03)	18.2507
2000's	7 (24.14)	29.6817
2010's	11 (37.93)	24.3611
2020's	2 (6.90)	2.80

Authors

Authors	Studies
Aparicio, AM; Bonnefous, C; Darimont, BD; Douglas, KL; Govek, SP; Grillot, KL; Hager, JH; Joseph, JD; Julien, JD; Kahraman, M; Kaufman, JA; Lai, AG; Lee, KJ; Lu, N; Moon, MJ; Nagasawa, JY; Prudente, RY; Rix, PJ; Sensintaffar, J; Smith, ND	1
Lin, X; Luo, G; Ma, L; Ren, S; Wang, X; Wu, S; Xiang, H	1
Goloubeva, O; Kazi, A; Sabnis, GJ; Schech, A; Yu, S	1
Andò, S; Barone, I; Bornert, JM; Catalano, S; Emprou, C; Laverny, G; Malivindi, R; Metzger, D; Panza, S; Rizza, P; Rovito, D	1
Alexi, X; Bouwman, P; Dijcks, F; Jonkers, J; Klarenbeek, S; Liu, X; van de Ven, M; van der Burg, E; Zwart, W	1
Cheung, P; Kakit, C; Kiess, N; Parsons, R; Pegno, S; Poulikakos, PI; Schmidt, H; Stratikopoulos, EE; Szabolcs, M; Wu, X	1
Bonnefoi, H; Grellety, T; Iggo, R; MacGrogan, G; Richard, E; Velasco, V	1
Greene, AL; Kundel, DW; Kundel, KD; Regal, RR; Rose-Hellekant, TA; Skildum, AJ; Zhdankin, O	1
Bocchinfuso, W; Conaway, M; Fan, P; Korach, KS; Li, Y; Liu, G; Santen, R; Wang, H; Wang, JP; Yue, W; Zhang, N	1
Brodie, A; Carboni, JM; Finckenstein, FG; Gottardis, MM; Greer, A; Haluska, P; Harrington, SC; Hou, X; Huang, F; Macedo, LF; Reeves, KA	1
Giulianelli, S; Gutkind, JS; Helguero, LA; Lamb, CA; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E	1
Glazer, RI; Kopelovich, L; Lu, J; Yin, Y; Yuan, H	1
Carlson, KE; Chan, SR; Dence, CS; Fettig, NM; Fowler, AM; Jeyakumar, M; Katzenellenbogen, JA; Schreiber, RD; Sharp, TL; Welch, MJ; Zhou, D	1
Giulianelli, S; Gutkind, JS; Helguero, L; Lamb, C; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E	1
Brodie, AM; Jelovac, D; Long, BJ; Thiantanawat, A	1
Aliaga, A; Bénard, F; Pepin, E; Rousseau, J; Seimbille, Y; Tessier, G; van Lier, JE	1
Brodie, A; Goloubeva, O; Jelovac, D; Macedo, L; Sabnis, G; Tilghman, S	1
Potter, BV; Purohit, A; Reed, MJ; Roberts, CJ; Williams, GJ	1
Coronado-Heinsohn, EB; Hilsenbeck, SG; Manning, DL; McClelland, RA; McCue, BL; Nicholson, RI; Osborne, CK; Wakeling, AE	1
Bouchoux, F; Brémaud, J; Hameau, MC; Lucas, D; Moratille, C; Nique, F; Philibert, D; Teutsch, G; Van de Velde, P; Viet, S	1
Biberger, C; von Angerer, E	1
Huynh, H; Pollak, M; Yang, XF	1
Brodie, A; Liu, Y; Long, B; Lu, Q; Wang, J; Yue, W	1
Huynh, H; Pollak, M	1
Coronado-Heinsohn, E; Gooch, JL; Hilsenbeck, SG; Jackson, JG; Lee, AV; Osborne, CK; Yee, D	1
Brodie, A; Gimbel, M; Grigoryev, D; Liu, Y; Long, BJ; Lu, Q	1
De Los Reyes, A; England, G; Jordan, VC; Lee, ES; O'Regan, RM; Schafer, JM; Yao, K	1
Chan, TW; Huynh, H; Mark, G	1
Ahmed, Y; Bentrem, DJ; Chisamore, MJ; Jordan, VC; Tonetti, DA	1

Reviews

1 review(s) available for fulvestrant and Experimental Mammary Neoplasms

Article	Year
Therapeutic observations in MCF-7 aromatase xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-15, Volume: 11, Issue:2 Pt 2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Nitriles; Receptors, Estrogen; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2005

Article

Year

Therapeutic observations in MCF-7 aromatase xenografts.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-15, Volume: 11, Issue:2 Pt 2

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Nitriles; Receptors, Estrogen; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2005

Other Studies

28 other study(ies) available for fulvestrant and Experimental Mammary Neoplasms

Article	Year
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft. Bioorganic & medicinal chemistry letters, 2019, 02-01, Volume: 29, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cinnamates; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Indazoles; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen	2019
Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer. European journal of medicinal chemistry, 2021, Dec-15, Volume: 226 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Development; Drug Screening Assays, Antitumor; Estrogen Receptor alpha; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Structure-Activity Relationship; Tetrahydroisoquinolines; Tumor Cells, Cultured	2021
Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity. The Journal of steroid biochemistry and molecular biology, 2020, Volume: 202 Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cinnamates; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Indoles; Mammary Neoplasms, Experimental; Mice, Nude; Postmenopause; Selective Estrogen Receptor Modulators	2020
Conditional expression of Ki-Ras Oncogene, 2017, 11-16, Volume: 36, Issue:46 Topics: Adenocarcinoma; Animals; Epithelium; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Gene Expression; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Mutation, Missense; Tumor Cells, Cultured	2017
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling. The Journal of pathology, 2018, Volume: 246, Issue:1 Topics: Animals; BRCA1 Protein; Carcinoma in Situ; Cell Proliferation; Cell Transformation, Neoplastic; Drug Implants; Estradiol; Estrenes; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogen Replacement Therapy; Female; Fulvestrant; Mammary Neoplasms, Experimental; Mice, 129 Strain; Mice, Transgenic; Ovariectomy; Progesterone; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Proteins	2018
Mouse ER+/PIK3CA Oncogene, 2019, Volume: 38, Issue:1 Topics: Aniline Compounds; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Cocarcinogenesis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation, Missense; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Sulfonamides; Thiazoles	2019
The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours. The Journal of pathology, 2016, Volume: 240, Issue:3 Topics: Animals; Antineoplastic Agents; Apocrine Glands; Breast Neoplasms; Cellular Microenvironment; Disease Models, Animal; Estradiol; Female; Fulvestrant; Heterografts; Humans; Ki-67 Antigen; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Piperazines; Pyridines; Receptor, ErbB-2; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone	2016
Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors. Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:5 Topics: Animals; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Immunohistochemistry; Incidence; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Transforming Growth Factor alpha	2009
Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. International journal of cancer, 2010, Oct-15, Volume: 127, Issue:8 Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Mice, Transgenic; Nitriles; Ovariectomy; Triazoles; Wnt1 Protein	2010
Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer. Cancer research, 2011, Dec-15, Volume: 71, Issue:24 Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Oligonucleotide Array Sequence Analysis; Pyrazoles; Receptor, IGF Type 1; Receptor, Insulin; Tamoxifen; Triazines; Triazoles; Xenograft Model Antitumor Assays	2011
Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer research, 2012, May-01, Volume: 72, Issue:9 Topics: Animals; Breast Neoplasms; Cell Growth Processes; Cell Nucleus; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, Reporter; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Receptors, Progesterone	2012
Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy. Oncotarget, 2012, Volume: 3, Issue:3 Topics: 9,10-Dimethyl-1,2-benzanthracene; Anilides; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; Chemoprevention; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Mice; Microarray Analysis; Molecular Targeted Therapy; PPAR gamma	2012
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Neoplasm Transplantation; Norpregnenes; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Receptors, Steroid; STAT1 Transcription Factor	2012
[The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins]. Medicina, 2012, Volume: 72, Issue:4 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Genes, myc; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Murinae; Progestins; Receptors, Progesterone; Transcription, Genetic	2012
The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7 Topics: Animals; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; In Vitro Techniques; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles; Tumor Cells, Cultured	2002
Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780). Nuclear medicine and biology, 2004, Volume: 31, Issue:6 Topics: Animals; Estradiol; Estrogen Receptor Modulators; Female; Fluorine Radioisotopes; Fulvestrant; Indicators and Reagents; Isotope Labeling; Mammary Neoplasms, Experimental; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sulfates; Tissue Distribution; Uterus	2004
In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. International journal of cancer, 1995, Sep-27, Volume: 63, Issue:1 Topics: Animals; Arylsulfatases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrone; Female; Fulvestrant; Liver; Mammary Neoplasms, Experimental; Rats; Rats, Wistar; Steryl-Sulfatase; Sulfatases; Tamoxifen; Time Factors	1995
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. Journal of the National Cancer Institute, 1995, May-17, Volume: 87, Issue:10 Topics: Analysis of Variance; Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Tamoxifen	1995
RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. The Journal of steroid biochemistry and molecular biology, 1994, Volume: 48, Issue:2-3 Topics: Animals; Antineoplastic Agents; Cell Division; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Progesterone; Rabbits; Rats; Receptors, Estrogen; Tamoxifen; Thymus Gland; Tumor Cells, Cultured; Uterus	1994
2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:1 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cattle; Cell Division; Estradiol; Estrogen Antagonists; Estrone; Female; Fulvestrant; HeLa Cells; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Organ Size; Receptors, Estrogen; Sulfur; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured; Uterus; Vitellogenins	1996
A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:11 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Carcinogens; Carcinoma; Cell Division; Culture Media, Conditioned; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 5; Mammary Neoplasms, Experimental; Oligonucleotides, Antisense; Rats; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	1996
The effects of aromatase inhibitors and antiestrogens in the nude mouse model. Breast cancer research and treatment, 1998, Volume: 50, Issue:1 Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Nitriles; Tamoxifen; Triazoles; Tumor Cells, Cultured	1998
Stabilization of mammary-derived growth inhibitor messenger RNA by antiestrogens. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:11 Topics: Animals; Breast Neoplasms; Carrier Proteins; Cell Nucleus; Estradiol; Estrogen Antagonists; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Fulvestrant; Genes, Tumor Suppressor; Growth Inhibitors; Half-Life; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Organ Culture Techniques; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tamoxifen; Transcription, Genetic	1997
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Molecular endocrinology (Baltimore, Md.), 1999, Volume: 13, Issue:5 Topics: Animals; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Phosphoproteins; Phosphorylation; Receptor, Insulin; Receptors, Estrogen; Receptors, Somatomedin; Signal Transduction; Somatomedins; Survival Rate; Transplantation, Heterologous; Tumor Cells, Cultured	1999
The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer. Breast cancer research and treatment, 1999, Volume: 57, Issue:2 Topics: Analysis of Variance; Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Tamoxifen; Time Factors; Triazoles; Tumor Cells, Cultured	1999
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:12 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stilbenes; Tamoxifen; Time Factors; Toremifene; Tumor Cells, Cultured	2000
Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate. International journal of oncology, 2001, Volume: 19, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Cell Differentiation; Cell Division; Drug Therapy, Combination; Epithelial Cells; Estradiol; Female; Fulvestrant; Immunohistochemistry; Ki-67 Antigen; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Testosterone; Time Factors	2001
Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Division; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Isoenzymes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Protein Kinase C; Protein Kinase C-alpha; Receptors, Estrogen; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001